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Abstract
The aim of this study was to test whether a combination of plant bioactive lipid compounds
(also termed ‘essential oils’) and biotin (PBLC+B) could decrease the mobilization of body
reserves and ketosis incidence in postpartum dairy cows. We compared non-supplemented
control (CON) cows with cows receiving monensin (MON) as a controlled-release capsule
at d -21, and with cows receiving PBLC+B from day (d) -21 before calving until calving
(Phase 1) and further until d 37 after calving (Phase 2), followed by PBLC+B discontinuation
from d 38 to d 58 (Phase 3). The PBLC+B cows had higher body weight and higher back fat
thickness than CON cows and lesser body weight change than MON and CON cows in
Phase 3. Body condition score was not different among groups. Milk protein concentration
tended to be higher on the first herd test day in PBLC+B vs. CON cows. Milk fat concentra-
tion tended to be highest in PBLC+B cows throughout Phases 2 and 3, with significantly
higher values in PBLC+B vs. MON cows on the second herd test day. Yields of energy-cor-
rected milk were higher in PBLC+B vs. CON and MON cows in Phase 2 and higher in PBLC
+B and MON cows vs. CON cows in Phase 3. The incidence of subclinical ketosis was 83%,
61% and 50% in CON, PBLC+B and MON cows, respectively, with lower mean β-hydroxy-
butyrate values in MON than in PBLC+B cows in Phase 1 prepartum. The serum triglyceride
concentration was higher in PBLC+B vs. CON cows on d 37. No differences were observed
in serum glucose, urea, non-esterified fatty acids, cholesterol and bilirubin concentrations.
Aspartate transaminase and γ-glutamyltranspeptidase but not glutamate dehydrogenase
activities tended to be highest in MON and lowest in PBLC+B in Phase 2. We conclude that
PBLC+B prevent body weight loss after parturition and are associated with similar ketosis
incidence and partly higher yields of energy-corrected milk compared to MON supplementa-
tion of dairy cows.
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Introduction
High-yielding dairy cows regularly experience metabolic challenges in early lactation. Follow-
ing calving, their energy demand rises greatly because of the onset of milk production and the
metabolic priority of the mammary gland [1–3]. In addition to significant energy output, espe-
cially via milk fat, lactose production is challenging because the demand of glucose rises
abruptly [4]. A shortage of glucose leads to instant hormonal adaption via an increasing gluca-
gon:insulin ratio [5], one major consequence being the mobilization of large amounts of body
fat [6–8]. The mobilized non-esterified fatty acids (NEFA) can serve as an energy fuel in tissues
capable of β-oxidation. For tissues not capable of β-oxidation (e.g. neuronal tissues), the liver
produces ketone bodies as a glucose-substituting energy fuel [1, 6]. Despite their roles as essen-
tial metabolic fuels, high concentrations of ketone bodies and NEFA lead to redox damage [9,
10] and are associated with production losses and health disturbances, commonly referred to
as ketosis of transition dairy cows. Clinical ketosis is easily detectable based on clinical signs
such as the abrupt loss of appetite, decreased milk performance and neuronal (shivering, apa-
thy, disorientation, blindness, cramps) and gastrointestinal (decreased ruminal motility, con-
stipation) signs [6, 11–13]. The more subtle forms of subclinical ketosis are not as easily
detectable because the associated weight and production losses are not linearly related to the
degree of lipomobilization and ketone body production. In serum, minimum ketone body
thresholds that provide an acceptable specificity for the prediction of health disturbances and
production losses on the individual cow level have mostly been identified as lying between 1.2
to 1.4 mmol/L β-hydroxybutyric acid (BHB) [14].
Subclinical ketosis is highly prevalent in transition dairy cows with typical herd incidences
of between 40 to 60% [15, 16]. The costs attributable to associated diseases and production
losses have recently been estimated at $289 per case of hyperketonemia in the US [17]. The
reduction of ketosis incidence is therefore a key issue in current dairy herd management and
dairy research. Because a glucose deficit is the ultimate trigger for ketone production, major
prevention strategies include the provision of gluconeogenic precursors in the form of feed
additives or the modulation of ruminal fermentation to increase ruminal propionate produc-
tion [4]. Ionophore antibiotics, especially monensin (MON), are potent enhancer of ruminal
propionate production [18–20] and are thus widely used in many countries around the time of
calving for the prevention of ketosis [15, 21] and associated diseases [22]. However, their pro-
phylactic use has low public acceptance in several countries and was, for example, banned in
the EU in 2006 [23]. In 2013, the reintroduction of MON into the European market as the con-
trolled-release capsule Kexxtone1 (Elanco, Indianapolis, IN, USA) for targeted metaphylactic
use to prevent hyperketonemia and associated diseases in risk animals [24] re-initiated a gen-
eral public debate about antibiotic use in farming, especially, in Germany [25]. Therefore,
despite the proven efficacy of the MON controlled-release capsule in ketosis prevention [21,
26, 27], alternative methods of ketosis prevention is an urgent need. Plant bioactive lipid com-
pounds (PBLC), especially those traditionally referred to as ‘essential oils’, could provide such
alternatives based on their antimicrobial effects [28–30] with the potential of stimulating rumi-
nal propionate fermentation [31, 32]. Biotin, on the other hand, is a cofactor of propionyl-
CoA carboxylase and pyruvate carboxylase [33] and might thus support gluconeogenesis at the
level of intermediate metabolism [34–36]. In a preceding study, we have observed improved
ruminal propionate fermentation and decreased loss of body condition in postpartum dairy
cows when supplemented with both PBLC and biotin [32], named PBLC+B hereafter. The aim
of the present study has been to substantiate such beneficial effects of PBLC+B on body condi-
tion with an additional focus on energy metabolism and milk performance when compared
with untreated control (CON) cows. In the extension of our previous study, our intension has
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also been to compare the effects of PBLC+B with those of a widely applied metaphylactic
scheme involving the use of MON.
Materials and methods
Animals, housing, feeding and treatments
The study was performed on a commercial dairy farm in Lower Saxony (Germany) and was
approved by the State Office of Lower Saxony for Consumer Protection and Food Safety (ref.
33.12-42502-04-14/1661). The farm housed a total of 140 Holstein dairy cows. The study
included 58 multiparous cows. It began in November 2014 and lasted until September 2015.
Each cow remained in the trial for 11 weeks, starting on day (d) -21 before the expected calving
date until d 58 postpartum. Cows were fed a partial mixed ration (PMR) and concentrates
based on the recommendations of the Society of Nutrition Physiology (GfE) [37], allowing for
5% orts. The concentrates consisted of a basal concentrate C1 that was provided in the dry and
lactation periods as explained later and a protein-rich concentrate C2 that was provided in the
lactation period only (Table 1).
Before the start of the study, cows were blocked according to their day of expected calving,
average milk yield in previous lactations, number of parturition and sex of the first calf and
then randomly assigned to treatment within block. Sex of first calf was used as a blocking crite-
rion because it has an epigenetic link to milk yield [38]. The first treatment group received 2 g/
d CRINA1 Ruminants and 40 mg/d ROVIMIX1 Biotin (both from DSM Nutritional Prod-
ucts Ltd, Kaiseraugst, Switzerland). Treatment PBLC+B was provided as a daily feed supple-
ment contained in 1 kg pelleted concentrate C1, named C1PBLC+B hereafter (Table 1). The 1
kg C1PBLC+B was supplied to each cow individually as a single portion once a day from d
-21 before expected calving until d 37 after calving. CRINA1 Ruminants is a proprietary mix-
ture of PBLC containing thymol, eugenol, limonene and vanillin as the main bioactive ingredi-
ents. It is a listed and authorized feed additive (list for feed additives of the EU (Reg 1831/
2003), FEMA (Flavor and Extracts Manufacturers Association) and the GRAS (Generally Rec-
ognised as Safe) database of the US Food and Drug Administration). The recommended PBLC
dose for lactating dairy cows is 1 g/d. Biotin is recommended at doses of 20 mg/d for lactating
dairy cows [39, 40]. The recommended dosages were doubled in the present study as these
higher dosages had proven effective in our previous study [32]. Furthermore, PBLC have dose-
dependent effects on ruminal fermentation [31] and performance [41] that extend beyond the
currently recommended dose by the supplier. Higher doses of 40 mg/d biotin have been asso-
ciated with marginal additional benefits for milk protein content [42] and beneficial effects in
the treatment of sole ulcers [43]. Each cow of the second treatment group received a single
MON controlled-release capsule (Kexxtone1) on d -21 by using a rumen bolus applicator.
The controlled-release capsule is designed to release ~335 mg/d MON into the rumen over a
period of 95 d according to the information deposited at the (European) Community Register
of Veterinary Medicinal Products (http://ec.europa.eu/health/documents/community-
register/html/v145.htm). A third group served as a control (CON) and received neither the
PBLC+B feed supplement nor the MON rumen bolus.
From d -21 until parturition, cows remained in a separate barn with a straw-bedded pen.
To increase comfort levels and to minimize ranking fights, the pen was subdivided into units
of ~30 m2 in which up to three cows were kept at a time. The pen was equipped with a feeding
fence in which the cows were fixed to receive their manually allocated concentrate portion at
09:30 h. The distance between cows was such that every cow only had access to its individual
concentrate portion, i.e. 1 kg/d concentrate C1 for cows in groups CON and MON and 1 kg/d
concentrate C1PBLC+B for cows in group PBLC+B. Once cows had consumed their
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Table 1. Ingredients, analyzed chemical composition and energy contents of partial mixed ration and concentrates used in close-up and lactation diets.
Partial mixed ration1 Concentrate2
Close-up Lactation C13 C1PBLC+B C24
Ingredients (as fed) g/kg g/kg g/kg g/kg g/kg
Grass silage 423 528
Corn silage 423 407
Straw 95 4
Wheat 20 155 155
Protein booster5 42 29
Premix P16 17
Premix P27 12
Rape extraction meal 270 270 330
Soy extraction meal 330
Corn 180 178 330
Sugar beet molasses 10
Palm kernel expeller 250 250
Molassed beet pulp 50 50
Dried beet pulp 50 50
Sugar beet molasses 15 15
Glucose molasses 10 10
Rapeseed 10 10
Calcium carbonate 8 8
Sodium chloride 1 1
Premix P38 1 1
CRINA1 Ruminants9 2
ROVIMIX Biotin9 0.04
Dry matter (DM) 360 ± 11.6 358 ± 6.9 894 ± 5.2 893 ± 5.5 887 ± 4.2
Chemical composition g/kg DM g/kg DM g/kg DM g/kg DM g/kg DM
Crude ash 90 ± 2.2 89 ± 2.8 60 ± 1.0 64 ± 0.6 59 ± 0.0
Crude protein 136 ± 4.9 143 ± 3.7 196 ± 2.6 202 ± 3.2 305 ± 5.6
Utilizable crude protein 138 ± 2.5 143 ± 3.7
Crude fibre 250 ± 9.5 235 ± 8.7 111 ± 8.0 128 ± 3.9 86 ± 3.7
Crude fat 36 ± 1.0 42 ± 3.1 38 ± 1.7 34 ± 4.0 36 ± 1.5
Sugar 10 ± 3.7 13 ± 3.1 80 ± 3.5 85 ± 5.4 67 ± 3.8
Starch 109 ± 11.0 125 ± 11.5 283 ± 5.7 235 ± 1.5 297 ± 3.0
aNDFom10 467 ± 10.7 448 ± 8.7 308 ± 4.8 341 ± 0.9 191 ± 5.0
ADFom10 260 ± 9.1 244 ± 9.6 166 ± 5.8 203 ± 0.7 125 ± 4.4
ADL10 27 ± 0.8 24 ± 1.7 53 ± 1.2 73 ± 1.2 41 ± 0.7
NFC10 271 ± 9.4 279 ± 5.1 398 ± 8.4 359 ± 2.9 408 ± 1.7
Energy MJ/kg DM MJ/kg DM MJ/kg DM MJ/kg DM MJ/kg DM
Metabolic energy 10.0 ± 0.2 10.4 ± 0.3 12.6 ± 0.1 12.3 ± 0.1 13.3 ± 0.0
(Continued)
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concentrate feeds, they were released from the feeding fence and the first half of PMR was
served at 10:00 h, followed by the second half of PMR at 18:00 h. The dry matter (DM) allow-
ance from PMR was 12 kg/d in the close-up period. The composition of the PMR is shown in
Table 1.
After calving, cows were moved to a free stall barn equipped with 110 lying places for an
average of 125 cows in milk. The barn area was divided into two milking units, each served by
a Lely Astronaut A4 milking robot (Lely S.à.r.l., Maassluis, The Netherlands). The milking
robot allowed up to 4 daily visits per cow; each visit included the weighing of cows, milking,
and feeding of a concentrate aliquot. To assure the consumption of the daily PBLC+B dose by
each individual cow, 1 kg/d concentrate C1 was supplied first during the first daily milking.
This first kilogram of concentrate C1 was either not supplemented (CON and MON groups)
or supplemented with PBLC+B (i.e. concentrate C1PBLC+B for cows of the PBLC+B group).
The remaining daily allocation of concentrate consisted of equal parts of C1 and C2 (Table 1).
The total daily concentrate allowance started with 3 kg/d after calving, was increased incre-
mentally by 100 to 250 g/d between d 1 and d 6 and was further increased by 250 g/d between
d 7 to 25 to a final allowance of 8.5 kg/d that was maintained until the end of the study. The
unused concentrate allowance was recorded in order to calculate concentrate intake. Postpar-
tum lactating cows were fed PMR for lactating cows (Table 1) at a feedbunk twice daily at
09:00 and 17:00 h. The average DM allowance from PMR was 16.6 kg/d in the lactation period.
Health was monitored daily by visual inspection and by the assessment of data from the
milking robot. In addition to concentrate intake, BW and milk performance, the data from the
milking robot included a physical activity index and rumination time of each cow. For this
Table 1. (Continued)
Partial mixed ration1 Concentrate2
Close-up Lactation C13 C1PBLC+B C24
Net energy for lactation 6.0 ± 0.1 6.3 ± 0.2 7.9 ± 0.0 7.5 ± 0.1 8.4 ± 0.0
1Samples were taken weekly and pooled over two months for chemical analyses; chemical analysis data are means ± SEM of four (close-up diet) to five analyses
(lactation diet).
2Samples were taken weekly and pooled over two or four months for chemical analysis; chemical analysis data are means ± SEM of three analyses.
3Based on milk-performance feed TvP Exclusiv 18/7 (Trede & von Pein)
4Based on soybean meal:rapeseed meal:corn, 1:1:1 (Trede & von Pein, Dammfleth, Germany)
5Protein booster, Lacto36solo (Trede & von Pein) containing (per kg): 480 g rape extraction meal, 480 g steam-heated soy extraction meal, and 40 g sugar beet molasses
6Premix P1, SALVAmin Prenatal TR-40 (with SALVANA dairy vital complex) (SALVANA Tiernahrung GmbH, Sparrieshoop, Germany) containing (per kg): 299 g
MgO2, 258 g Ca(H2PO4)2, 220 g NaCl, 60 g wheat, 47 g sugar beet pulp, 20 g sugar beet molasses, 10 g fruit pulp, vitamin and mineral mix (the latter containing 900,000
IU vitamin A, 200,000 IU vitamin D3, 10,000 mg vitamin E, 950 mg Cu as CuSO4×5H2O, 250 mg Cu as Cu2(OH)3Cl, 5,500 mg Zn as ZnO, 1000 mg Zn as ZnCl
(OH)×H2O, 5,000 mg Mn as MgO2, 50 mg I as Ca(IO3)2, 35 mg Se as Na2SeO3, 10 mg Se as rumen-protected Na2SeO3, 5 mg Se in organic form as Saccharomyces
cerevisae, 50 mg Co as CoCO3, and 33 × 109 KBE Saccharomyces cerivisea)
7Premix P2, SALVANA Rinderstolz 9848 GF 600 (SALVANA Tiernahrung GmbH) containing (per kg): 336 g RaPass, 334 g calcium salts of palm oil fatty acids, 87 g
calcium carbonate, 86 g sodium chloride, 56 g monocalciumphosphat, 30 g magnesiumoxid, 12 g sugar beet molasses,190,000 IU vitamin A, 19,000 IU vitamin D3, 1,500
mg vitamin E, 288 mg Cu as CuSO4×5H2O, 72 mg Cu as Cu2(OH)3Cl, 1,100 mg Zn as ZnO, 300 mg Zn as ZnCl(OH)×H2O, 100 mg Zn as glycin zinc chelate hydrate,
1,140 mg Mn as MgO2, 14 mg I as Ca(IO3)2, 6 mg Se as Na2SeO3, 4 mg Se as rumen-protected Na2SeO3, 9 mg Co as CoCO3×H2O, and 33 × 109 KBE Saccharomyces
cerevisiae
8Premix P3, Premix cow 0.1% 8399 (Trede & von Pein) containing (per kg): 938 g calcium carbonate, 7,500,000 IU vitamin A, 875,000 IU vitamin D3, 19 g Mn as MgO3,
0.1 g I as Ca(IO3)2, 0.4 g Se as Na2SeO3, 0.2 g Co as CoCO3×H2O, 40 g Zn as ZnO
9Analyzed concentrations in the final C1PBLC+B concentrate were 1.03 g/kg PBLC and 0.034 g/kg biotin.
10aNDFom = Neutral detergent fiber corrected for residual ash and analyzed with amylase; ADFom = acid detergent fiber corrected for residual ash; ADL = acid
detergent lignin; NFC = non-fibre carbohydrates [100 - (% aNDFom + % crude protein + % crude fat + % crude ash)].
https://doi.org/10.1371/journal.pone.0193685.t001
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purpose, the neck collar of each cow was equipped with a Lely Qwes-HR System (including
acceleration sensor, rumination microphone, microprocessor and memory) from which the
continuously logged data were downloaded during milking. Health disturbances were treated
by the farm veterinarian and were recorded. Special attention was given to the occurrence of
clinical ketosis. The latter was diagnosed based on the clinical signs listed in the Introduction
and concurrently high serum BHB concentrations with a cautious interpretation of clinical
signs when 1.4 BHB < 3.0 mmol/L and strict interpretation of clinical signs when BHB
3.0 mmol/L. Based on predefined exclusion criteria for severe or recurrent diseases, two cows
of the CON group had to be excluded because of a displaced abomasum, one cow in the MON
group because of multiple mastitis and two cows in the PBLC+B group because of a displaced
abomasum or multiple mastitis. Thus, the finally analyzed group sizes were 17, 18 and 18 cows
in the CON, PBLC+B and MON groups, respectively.
Sampling
The sampling of blood and the assessment of back fat thickness (BFT) and body condition
score (BCS) were always carried out at the same time of the day between 07:30 and 08:30. For
practical reasons, sampling days were Mondays, Wednesdays and Fridays based on the
expected (prepartum values) or real (postpartum values) calving dates of each individual cow.
Target sampling days were d -21, -14, -7 before calving and d 2, 9, 16, 23, 30, 37, 44, 51, 58
after calving, this timing being achieved with a variation of ± 1 d after calving. However, as
calving varied from the predicted date by several days, d -21 was defined as the day of the
inclusion in the study and finally varied by ± 4 d to the real d -21. Day -7 was defined as the
last sampling at least 4 d prior to real calving, i.e. d -7 ± 3. Day -14 was not available in some
cows that calved earlier than expected and was thus removed from the data set.
Blood sampling and analyses
The blood samples were collected from the coccygeal vein by using one 10-mL monovette with
clot activator/additive carrier (S-Monovettes, Sarstedt, Nu¨mbrecht, Germany). Within 1–2 h
after taking the blood samples, serum was separated by centrifugation at 3000 g for 10 min
(centrifuge Z364, BHG Hermle GmbH u Co., Gosheim, Germany) and stored at -20˚C until
analysis. The serum concentrations of glucose, BHB, NEFA, triglycerides, bilirubin, cholesterol
and urea and the serum activities of aspartate transaminase (AST), γ-glutamyltranspeptidase
(GGT) and glutamate dehydrogenase (GLDH) were measured by a Cobas C 311 (Roche Diag-
nostics Deutschland GmbH, Mannheim, Germany) in the Laboratory of the Clinic for Internal
Veterinary Medicine of Leipzig University (Leipzig, Germany) with ready-to-use e pack
reagents (Roche Diagnostics Deutschland GmbH).
Body condition score and back fat thickness
The BCS was evaluated on a scale from 1 (emaciated) to 5 (overweight) in increments of 0.25
according to Edmonson et al. [44] with the only modification being that the transverse pro-
cesses were assessed by using both visual and tactile assessment. The BCS was always assessed
by the same trained person. The BFT was measured by ultrasound with an Eickemeyer Magic
1100 Smart Scanner equipped with a linear transducer as recommended by Staufenbiel [45].
The measuring point laid on the connecting line between the upper part of the Tuber ischiadi-
cum and the upper part of the Tuber coxae, at one hand width cranial of the Tuber ischiadi-
cum. The measurement included the skin and subcutaneous fat up to the Fascia trunci
profunda. Ethanol (70%; Carl Roth GmbH u Co. KG, Karlsruhe, Germany) was used as a cou-
pling medium on non-depilated skin [45].
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Body weight (BW)
The average body weight per cow per day was automatically calculated daily by the milking
robot software by using the body weight recorded before each milking, which was up to four
times per day.
Milk yield and milk components
The milk yield was recorded by the milking robot at each milking and was summed by the soft-
ware of the milking robot per cow per day. Milk components were determined in the monthly
herd test by the MKV EW (Milchkontrollverband Elbe-Weser e.V., Hankensbu¨ttel, Germany),
which was performed if cows were 5 DIM. Milk sample collection on test days included all
milkings in a 24-h sampling period by using the ICAR-approved Lely Shuttle milk sampling
unit (Lely S.à.r.l.). The concentrations of fat, crude protein and urea were analyzed by infrared
spectrophotometry and somatic cell count by flow cytometry using Combi Foss (Foss Electric,
Hillerød, Denmark). In addition to the data from the milk test days, the milking robot was
equipped with flow velocity, conductivity and optical sensors to estimate the daily milk fat and
protein percentages according to proprietary algorithms. The latter data were used to extrapo-
late the daily energy-corrected milk yield (ECM). The ECM was calculated using the formula
of German herd testing organizations (LKV) extrapolating to 40 g/kg fat and 34 g/kg crude
protein (equivalent to 32 g/kg true protein): ECM (kg/d) = milk yield (kg/d) × [0.038 × fat (g/
kg) + 0.021 × protein (g/kg) + 1.05] / 3.28.
Feed analysis
Samples of PMR were taken weekly directly after feed supply at 5–10 different places on the
feeding table. The samples were stored in labelled freezer bags at -20˚C and pooled over two
months before analysis. Samples of concentrates were taken weekly from the concentrate silos,
stored in labelled freezer bags at -20˚C and pooled over two to four months before analysis.
Feed analyses were performed in the laboratory of the LKS Landwirtschaftliche Kommunika-
tions und Service GmbH (Lichtenwalde, Germany) according to standard procedures [46].
Dry matter was determined in a drying cabinet (VDLUFA MB III 3.1). For concentrates,
crude ash was determined in a muffle furnace at 550˚C (VDLUFA III 8.1). Starch was deter-
mined by using a polarimeter (VDLUFA MB III 7.2.1), crude fat by the Soxhlet method with
hydrolysis (VDLUFA MB III 5.1.1) and crude protein by incineration (VDLUFA MB III
4.1.2). Acid detergent fibre expressed exclusive of residual ash (ADFom) was determined by
using FibertecTM 8000 (FOSS, Hilleroed, Denmark; method, VDLUFA MB III 6.5.2). Neutral
detergent fibre (comparable to assay with heat-stable amylase and expressed exclusive of resid-
ual ash; aNDFom), sugar, acid detergent lignin (ADL) and chemical components of PMR were
estimated by near-infrared spectroscopy according to the method VDLUFA MB III 31.2. Gas
formation for the estimation of net energy for lactation in feeds was measured by using the
Hohenheim Gas Test (VDLUFA MB III 25.1).
Statistical analysis
Statistical analyses were performed by using the software SAS (2001; version 8.2, SAS Institute
Inc, Cary, USA) and Sigma Plot 11.0 (Systat Software GmbH, Erkrath, Germany). Before all
analyses, data retrieved from the milking robot (BW, milk yield, milk composition and con-
centrate intake contained in Table 2, S1 Table, S2 Table, S1 Fig and S2 Fig) were pooled over
three consecutive days; e.g. values for d 2 represent the arithmetic mean of d 1 to 3. Data were
allocated to three experimental phases: the prepartum Phase 1 including d -21 to d -1, the
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PBLC+B supplementation Phase 2 from d 1 to d 37, and the post-supplementation Phase 3
from d 38 to d 58. Data were analyzed as a randomised block design using the mixed model
procedure of SAS with repeated measures within a phase. The model contained group, parity
as block, day as the repeated measure with cow as subject, and interaction between group and
day as the main effects. The phases were distinct periods with respect to physiological stages
and dietary treatments, which were usually significantly varied for different response variables
in this study. Parity was excluded from the model, if it increased P-values. Random effect of
cow was included in the model, if it improved model fit according to Akaike (or Bayesian)
information criterion (AIC). Different covariance structures including compound symmetry
(type = cs), autoregressive (type = ar(1)), unstructured (type = un), variance components
(type = vc) and Toeplitz (type = toep) were evaluated and the best covariance structure was
finally selected according to the best model fit (smaller-is-better rule of the AIC values) and
lower P-values. Usually, statistical models containing random effect of cow, parity and autore-
gressive covariance structure showed better model fit. When the interaction between group
and day was significant (P< 0.05), the ‘slice’ option in the ‘lsmeans’ statement was used to
determine differences among the treatments at each day. Comparisons among overall groups
or groups at a day (if they were found to be significant based on the ‘slice’ option) were per-
formed using ‘diff’ option in the ‘lsmeans’ statement.
Data from individual days (Table 3 and all supporting material) were analyzed by Sigma
Plot 11.0 (Systat Software GmbH, Erkrath, Germany) and are expressed as means and pooled
SEM. Before statistical comparisons, data sets were tested for normality (Kolmogorov-Smir-
nov’s test with Lilliefors’ correction) and equal variance (Levene’s median test). If both tests
Table 2. Concentrate intake, body weight (BW), BW changes, body condition score and back fat thickness of cows receiving plant bioactive lipid compounds and
biotin (PBLC+B; n = 18) from d -21 to 37 relative to parturition, cows receiving a monensin bolus (MON; n = 18) at d -21 or cows receiving no such supplements
(CON; n = 17).
Item Group1 SEM P-values
CON PBLC+B MON Group Day Group × day
Phase 1
Body condition score 3.56 3.74 3.63 0.141 0.41 <0.001 0.15
Back fat thickness, cm 2.86 3.33 3.21 0.268 0.37 0.34 0.23
Phase 2
Concentrate intake, kg/d2 5.01 4.98 4.85 0.344 0.90 <0.001 0.003
Body condition score 2.89 3.09 2.99 0.100 0.26 <0.001 0.88
Back fat thickness, cm 1.96 2.50 2.27 0.197 0.099 <0.001 0.80
BW, kg 685b 746a 723ab 22.8 0.049 <0.001 0.39
BW change, kg -45 -19 -46 14.0 0.089 <0.001 0.48
Phase 3
Concentrate intake, kg/d 6.94 6.77 7.14 0.381 0.70 0.041 0.13
Body condition score 2.42 2.64 2.58 0.091 0.17 <0.001 0.73
Back fat thickness, cm 1.18b 1.65a 1.51ab 0.145 0.048 <0.001 0.81
BW, kg 663b 750a 689ab 24.6 <0.001 0.57 0.67
BW change, kg -72b -19a -65b 14.9 0.002 <0.001 0.92
Phase 1: from d -21 to d -1 relative to parturition; Phase 2: from d 1 to d 37 relative to parturition; Phase 3: from d 38 to d 58 relative to parturition. SEM = standard
error of mean (for group × day).
1Least square mean values of the groups are reported.
2For concentrate intake, diet effect was not significant at any individual day.
abSuperscript letters indicate differences among treatment groups at P< 0.05.
https://doi.org/10.1371/journal.pone.0193685.t002
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were passed, data at each time point were compared by one-way ANOVA. If either test failed,
the Kruskal-Wallis one-way ANOVA on ranks was performed. The multiple comparison pro-
cedure of Student-Newman-Keuls was performed to identify the means that differed.
Significant differences were accepted at P< 0.05. Trends were generally considered when
0.05< P< 0.10. However, trends for effects on milk and ECM yields were considered when
0.05< P< 0.15 because these variables appeared far outside the power range of the test design.
Results
General health records
No obvious differences were found in the clinical health status among groups. Clinical ketosis was
not observed (for subclinical ketosis, see later section). Postpartum diseases for all 58 cows that ini-
tially entered the study included retained placenta (MON, n = 2), metritis (CON, n = 5; PBLC+B,
n = 2; MON, n = 3), mastitis (CON, n = 4; PBLC+B, n = 6; MON, n = 6), lameness (CON, n = 4;
PBLC+B, n = 4; MON, n = 2) and displaced abomasum (CON, n = 2; PBLC+B, n = 1). Some cows
were given calcium (CON, n = 1; PBLC+B, n = 4; MON, n = 5) and/or phosphorous infusions
(CON, n = 2; PBLC+B, n = 1). Treatments and calcium and phosphorous infusions were applied
by the local veterinarian and cows generally responded well. However, five of the cows listed here
had to be excluded from further analyses based on pre-defined exclusion criteria, including dis-
placed abomasum and recurring mastitis (CON, n = 2; PBLC+B, n = 2; MON; n = 1).
Concentrate intakes
The concentrate intakes resulting from the concentrate allowance minus unused concentrate
allowance are listed in Table 2 for Phase 2 and Phase 3, and in S1 Table for individual days.
Day effect was significant (P< 0.05; Table 2) as expected. Group × day interaction was signifi-
cant in Phase 2 (P< 0.05; Table 2); however, no differences in concentrate intakes were noted
among groups at any specific day (S1 Table).
Body condition
Body condition was assessed based on BFT and BCS recorded weekly by the same operator,
whereas BW was recorded daily by the milking robot after the beginning of lactation and
Table 3. Milk performance on herd test days of cows receiving plant bioactive lipid compounds and biotin (PBLC+B) from d -21 to 37 relative to parturition, cows
receiving a monensin bolus (MON) at d -21 or cows receiving no such supplements (CON).
Item First test day Second test day
CON PBLC+B MON SEM P-value CON PBLC+B MON SEM P-value
Days after calving 22 20 21 4.4 0.55 54 52 53 5.2 0.86
Milk yield, kg/d 39.1 39.0 41.1 3.06 0.72 42.0 45.0 46.3 2.38 0.17
ECM yield, kg/d 40.4 41.5 42.2 2.67 0.52 40.6 44.4 42.7 2.31 0.13
Fat, % 4.59 4.64 4.53 0.276 0.93 3.97ab 4.09a 3.56b 0.160 0.004
Protein, % 3.11 3.32 3.18 0.092 0.076 2.98 3.04 2.98 0.066 0.53
Urea, mg/L 240 236 267 19.3 0.17 254 261 266 15.7 0.74
Somatic cell count, cells/L 4011 97 61 34.5 0.83 7411 124 169 71.2 0.45
Data are presented as means and pooled SEM of 17 cows in the CON group, 18 cows in the PBLC+B group and 18 cows in the MON group.
abSuperscript letters indicate differences among treatment groups at P< 0.05.
1The CON group included two cows with >1000 somatic cells/L at each test day
ECM = energy corrected milk; SEM = standard error of mean
https://doi.org/10.1371/journal.pone.0193685.t003
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pooled over three consecutive days. The BFT was not different in Phase 1 prepartum, but
PBLC+B cows showed a trend for values higher than CON in postpartal Phase 2 (P = 0.099)
and significantly higher values in Phase 3 (P = 0.048), with MON cows being intermediate.
Similarly, although least square mean (LSM) of BCS were not different for the three phases
(Table 2), BCS of PBLC+B cows showed a trend for values higher than CON at several individ-
ual days after parturition (d 9, 16, 23, 51 and 58; P< 0.1) with significantly higher values than
CON at d 44 (P< 0.05; S2 Table). A very clear effect was seen on BW. Cows of the PBLC+B
group had higher BW than CON in both Phase 2 and Phase 3 (P< 0.05; Table 2). When plot-
ting the BW change relative to d 2 after parturition, it became obvious that cows of the PBLC
+B group almost retained their parturition BW throughout the postpartum period in contrast
to CON and MON cows that showed a trend for higher BW loss in Phase 2 (P = 0.089) and sig-
nificantly higher BW loss in Phase 3 (P = 0.002; Table 2; S1 Fig).
Milk yield and milk components
The first and second herd tests were performed 20 to 22 (± 4.4) and 52 to 54 (± 5.2) d after
calving, respectively, with no differences among groups (Table 3). Daily milk yield was not dif-
ferent among groups on these days (Table 3). On the first herd test day, the milk fat concentra-
tion was not different among groups; however, a trend for higher milk protein concentration
was observed in the PBLC+B group compared with the other two groups (P< 0.1). The trend
for higher milk protein concentration did not continue until the second test day. Instead, milk
fat concentration was higher on the second test day in PBLC+B vs. MON cows (P< 0.01),
with CON cows showing intermediate values. Concomitantly, ECM yield showed a trend for
higher values in PBLC+B vs. CON cows (P = 0.13; Table 3). Milk urea concentration and
somatic cell count were not different among groups on the herd test days.
Data from the milking robot are presented in Table 4 and, for individual days, in the sup-
porting material (S1 Table and S2 Fig). Frequency of milk robot visits did not differ among
groups throughout the trial period (Table 4; S1 Table). Daily milk yield was not different
among groups in Phase 2 but was higher in MON vs. CON cows in Phase 2 (P = 0.001), with
PBLC+B cows showing intermediate values. The yield of ECM was higher in PBLC+B cows
compared to both CON and MON cows in Phase 2 (P< 0.001; Table 4). In Phase 3, ECM
yield was higher in PLBLC+B and MON cows compared with CON cows (P< 0.001; Table 4).
The higher yields of ECM in the PBLC+B group was based, in part, on a trend for higher esti-
mated milk fat percentage of cows of the PBLC+B group compared to both other groups in
Phase 2 and Phase 3 (P< 0.1), coinciding with a trend for higher milk fat yield in Phase 2
(P = 0.094; Table 4). An interaction between group × day (P = 0.01) indicated that estimated
milk fat percentage of PBLC+B cows was higher than that of CON cows at the beginning of
Phase 2 (d 5 and d 8), higher than that of MON cows in the middle of Phase 2 (d 20 and d 26)
and higher than that of MON and CON cows at the end of Phase 2 (d 35; P< 0.05; Table 4; S2
Fig). The estimated milk protein percentage and yield showed no difference among groups
(Table 4), except for individual d 2, when estimated milk protein percentage was higher in
PBLC+B cows compared with CON and MON cows (P< 0.05; S2 Fig).
Blood serum metabolites and enzymes
Key indicators of energy metabolism are shown in Table 5 for phases and in S3 Table for indi-
vidual days. Serum glucose concentrations generally decreased with progressing of trial days
in Phase 1 and Phase 2 (P< 0.01) with no differences among groups and with no interaction
effect between group and day in each of the three trial phases (Table 5). Serum NEFA values
peaked at d 2 after parturition followed by a progressive decrease throughout Phases 2 and 3
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(P< 0.01; Table 5; S3 Table), The peak in serum NEFA concentrations was followed by a peak
in BHB concentrations between 16 d to 30 d after parturition as indicated by day effects in
Phase 1 and Phase 2 (P< 0.01; Table 5; S3 Table). One prominent finding was a lower BHB
value in MON cows compared with PBLC+B cows in Phase 1 before parturition, with CON
cows having intermediate values (P< 0.05; Table 5). A trend for a group × day interaction
indicated that this was primarily due to lower BHB values in MON vs. CON and PBLC+B at d
-7 (P< 0.01; S3 Table). Based on a cut-off value of 1.4 mmol/L, the incidence of ketosis was
83% in CON, 61% in PBLC+B and 50% in MON cows over the whole trial period. Serum
NEFA concentrations did not differ among groups (Table 5). The triglyceride concentration
generally decreased after parturition in Phase 2 in all groups (P< 0.001). However, a
group × day interaction (P = 0.033) indicated that serum triglyceride concentrations were
higher in the PBLC+B group compared with the CON group on d 37 (Table 5; S3 Table).
Other metabolic indicators (cholesterol, bilirubin and urea; Table 5; S4 Table) and serum
activities of enzymes with relation to liver and muscle function (AST, GGT and GLDH;
Table 6; S5 Table) showed no differences among groups (P> 0.1), except for a trend for higher
AST and GGT values in MON in Phase 2 (P< 0.1; Table 6). Day effects were noted for most of
these variables in different phases. With advancing time of Phase 1, concentrations of choles-
terol and the activity of GGT generally decreased (P< 0.001); whereas, concentrations of bili-
rubin increased (P< 0.001). In Phase 2, the activity of AST decreased gradually (P< 0.001);
whereas concentrations of cholesterol, bilirubin and urea, as well as the activities of GGT and
GLDH, increased (P< 0.001). In Phase 3, the activity of GGT decreased (P = 0.045); whereas
Table 4. Milk robot visits, milk yield and milk composition of cows receiving plant bioactive lipid compounds and biotin (PBLC+B; n = 18) from d -21 to d 37 rela-
tive to parturition, cows receiving a monensin bolus (MON; n = 18) at d -21 or cows receiving no such supplements (CON; n = 17).
Item Group1 SEM P-values
CON PBLC+B MON Group Day Group × day
Phase 2
Milk robot visit per day 2.7 2.7 2.8 0.20 0.75 <0.001 0.17
Milk yield, kg/d 36.2 37.3 37.6 1.12 0.063 <0.001 0.99
ECM yield, kg/d 36.8b 39.5a 37.6b 0.48 <0.001 <0.001 1.00
Milk fat, %2 4.16 4.48 4.10 0.161 0.083 <0.001 0.010
Milk protein, % 3.55 3.63 3.55 0.060 0.35 <0.001 0.13
Fat yield, kg/d 1.55 1.74 1.58 0.081 0.094 0.003 0.99
Protein yield, kg/d 1.26 1.31 1.29 0.060 0.68 <0.001 0.84
Phase 3
Milk robot visit per day 3.1 3.2 3.1 0.21 0.89 0.86 0.83
yield, kg/d 43.6b 45.0ab 46.6a 1.10 0.001 1.00 1.00
ECM yield, kg/d 41.6b 45.0a 44.1a 0.63 <0.001 1.00 1.00
Milk fat, % 3.69 4.03 3.66 0.135 0.055 0.33 0.47
Milk protein, % 3.26 3.32 3.23 0.053 0.43 0.68 0.47
Fat yield, kg/d 1.61 1.82 1.69 0.079 0.12 0.97 0.89
Protein yield, kg/d 1.43 1.49 1.50 0.055 0.49 0.82 0.43
Phase 2: from d 1 to d 37 relative to parturition; Phase 3: from d 38 to d 58 relative to parturition. ECM = energy corrected milk; SEM = standard error of mean (for
group × day).
1Least square mean values of the groups are reported.
2For milk fat percentage: at d 5 and d 8, CON vs. PBLC+B: P< 0.05; at d 20 and d 26, MON vs. PBLC+B: P< 0.05; at d 35, CON vs. PBLC and MON vs. PBLC+B:
P< 0.05.
abSuperscript letters indicate differences among treatment groups at P< 0.05.
https://doi.org/10.1371/journal.pone.0193685.t004
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concentrations of cholesterol (P< 0.001) and urea (P = 0.014) increased (Tables 5 and 6; S4
and S5 Tables).
Discussion
To date, several nutritional intervention strategies have been developed to optimize energy
metabolism around parturition and, thereby, to decrease the incidence of subclinical ketosis of
dairy cows. As the pathophysiology of ketosis proceeds from a shortage of energy, especially in
the form of glucose [4, 47], most strategies target measures to increase energy density in the
diet and energy intake [48–50], measures to increase the supply of glucogenic precursors and
measures to enhance the conversion of glucogenic precursors to glucose [51–53].
In the present study, we used MON as one current ‘gold standard’ supplement that targets
ketosis prevention after calving [21, 54, 55]. The main action of MON is to increase ruminal
propionate production, thereby, increasing the supply of this glucogenic precursor [20, 21,
Table 5. Serum metabolite concentrations in cows receiving plant bioactive lipid compounds and biotin (PBLC+B; n = 18) from d -21 to 37 relative to parturition,
cows receiving a monensin bolus (MON; n = 18) at d -21 or cows receiving no such supplements (CON; n = 17).
Item Group1 SEM P-values
CON PBLC+B MON Group Day Group × day
Phase 1
Glucose, mmol/L 3.70 3.64 3.72 0.077 0.72 0.003 0.86
BHB, mmol/L 0.77ab 0.83a 0.68b 0.047 0.024 0.004 0.097
NEFA, mmol/L 0.15 0.17 0.20 0.035 0.40 <0.001 0.54
Triglycerides, mmol/L 0.29 0.31 0.28 0.018 0.35 0.10 0.39
Cholesterol, mmol/L 2.38 2.39 2.33 0.167 0.96 <0.001 0.98
Bilirubin, μmol/L 1.16 1.06 1.30 0.278 0.72 <0.001 0.65
Urea, mmol/L 4.17 4.32 4.35 0.187 0.66 0.20 0.27
Phase 2
Glucose, mmol/L 2.99 2.97 3.18 0.143 0.17 <0.001 0.34
BHB, mmol/L 1.64 1.48 1.33 0.183 0.28 <0.001 0.23
NEFA, mmol/L 0.45 0.48 0.43 0.059 0.36 <0.001 0.78
Triglycerides, mmol/L2 0.13 0.14 0.13 0.006 0.52 <0.001 0.033
Cholesterol, mmol/L3 2.82 2.98 2.90 0.185 0.78 <0.001 0.007
Bilirubin, μmol/L 2.81 2.13 2.94 0.519 0.18 <0.001 0.32
Urea, mmol/L 4.41 4.25 4.68 0.244 0.16 <0.001 0.82
Phase 3
Glucose, mmol/L 3.01 3.15 3.10 0.114 0.55 0.46 0.37
BHB, mmol/L 1.61 1.31 1.31 0.218 0.47 0.11 0.48
NEFA, mmol/L 0.19 0.20 0.21 0.023 0.78 0.001 0.65
Triglycerides, mmol/L 0.15 0.17 0.17 0.009 0.24 0.16 0.50
Cholesterol, mmol/L 4.48 4.78 4.80 0.271 0.60 <0.001 0.76
Bilirubin, μmol/L 0.73 0.82 0.98 0.157 0.28 0.37 0.12
Urea, mmol/L 5.07 4.86 5.14 0.226 0.52 0.014 0.47
Phase 1: from d -21 to d -1 relative to parturition; Phase 2: from d 1 to d 37 relative to parturition; Phase 3: from d 38 to d 58 relative to parturition. BHB = β-
hydroxybutyric acid; NEFA = non-esterified fatty acids; SEM = standard error of mean (for group × day).
1Least square mean values of the groups are reported.
2For triglyceride at d 37, CON vs. PBLC+B: P = 0.005.
3For cholesterol, treatment effect was not significant at any individual day.
abSuperscript letters indicate differences among treatment groups at P< 0.05.
https://doi.org/10.1371/journal.pone.0193685.t005
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56]. Previous trials have shown that PBLC can equally increase ruminal propionate production
[31, 32, 56] and, when combined with biotin as a cofactor of gluconeogenic enzymes (propio-
nyl-CoA carboxylase and pyruvate carboxylase; [33]), it can possibly provide additional bene-
fits for body condition [32].
To compare the effects of PBLC+B with those of MON, we performed a controlled study in
a commercial dairy herd that was managed according to very high standards but that neverthe-
less had a history of frequent cases of subclinical ketosis. We included all multiparous cows
that calved in the study period, because multiparous cows are especially prone to metabolic
dysfunctions in early lactation [57]. The design of the present study involved labour- and cost-
intensive in-depth investigations in a representative number of individual cows. As such, the
number of included cows did not allow a statistical comparison of general health benefits
among treatments. At a descriptive level, however, no obvious differences were seen among
the groups.
No clinical ketosis was observed during the course of the study. As expected from the herd
history, however, subclinical ketosis was highly prevalent throughout of the study, especially,
in the CON group. The cut-off points at which serum BHB concentrations of individual cows
are verifiably associated with diseases have mostly been identified between 1.2 and 1.4 mmol/L
[14]. Even when applying the higher value of 1.4 mmol/L, the incidence of subclinical ketosis
was 83% in the CON group. Ketosis incidence in the PCLB+B and MON groups was 61% and
50%, respectively, with MON additionally inducing a decrease in mean serum concentrations
of BHB around calving. This is in agreement with the previously established potential of MON
to decrease the incidence of subclinical ketosis in postpartum dairy cows [21, 54, 55] and fur-
thermore indicates a similar potential for the tested combination of PBLC+B.
Serum variables other than BHB were either not or not markedly altered by the two treat-
ments. Serum glucose concentrations were generally very low in all groups, especially immedi-
ately after calving. This was as expected, because the shortage of glucose is the ultimate trigger
Table 6. Serum activities of enzymes in cows receiving plant bioactive lipid compounds and biotin (PBLC+B; n = 18) from d -21 to 37 relative to parturition, cows
receiving a monensin bolus (MON; n = 18) at d -21 or cows receiving no such supplements (CON; n = 17).
Item Group1 SEM P-values
CON PBLC+B MON Group Day Group × day
Phase 1
AST, U/L2 67.4 67.2 79.7 5.66 0.16 0.33 0.045
GGT, U/L 23.6 24.8 25.7 1.74 0.65 <0.001 0.96
GLDH, U/L 11.0 11.2 12.5 2.63 0.88 0.12 0.088
Phase 2
AST, U/L 98.3 89.3 109.8 9.23 0.094 <0.001 0.55
GGT, U/L 29.1 27.5 33.9 2.15 0.093 <0.001 0.76
GLDH, U/L 18.7 16.1 20.3 6.26 0.79 <0.001 0.94
Phase 3
AST, U/L 80.9 70.9 83.9 5.53 0.107 0.59 0.48
GGT, U/L 30.7 30.4 36.2 2.64 0.16 0.045 0.49
GLDH, U/L 16.5 13.8 16.0 4.20 0.85 0.53 0.17
Phase 1: from d -21 to d -1 relative to parturition; Phase 2: from d 1 to d 37 relative to parturition; Phase 3: from d 38 to d 58 relative to parturition. AST = Aspartate
transaminase; GGT = γ-Glutamyl transpeptidase, U/L; GLDH = Glutamate dehydrogenase, U/L; SEM = standard error of mean (for group × day).
1Least square mean values of the groups are reported.
2For AST at d -7, CON vs. MON: P = 0.033 and PBLC+B vs. MON: P = 0.022.
One outlier for GLDH was removed in MON.
https://doi.org/10.1371/journal.pone.0193685.t006
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of ketone body production in the liver. The latter was recently substantiated by Ruoff et al.
[58] who identified that hypoglycaemia after calving is associated with the onset of hyperketo-
naemia in multiparous cows. When analysing individual days, occasional trends were noted
for higher serum glucose concentrations in the PBLC+B and MON groups and for lower urea
concentrations in the PBLC+B group. However, because the group and group × day P-values
for these variables were> 0.1, care should be taken to interpret this as indicators of improved
glucose and protein metabolism, respectively, especially when considering that other factors
can also have an impact on these metabolites. Serum triglyceride concentration was slightly
higher in the PBLC+B group on d 37, which may have some relationship to the higher milk fat
concentrations observed in this group (see later). On the other hand, serum concentrations of
NEFA, cholesterol and bilirubin were not different among groups.
The activity of the serum enzyme GLDH was also not different among groups. However,
AST and GGT activities tended to be highest in the MON and lowest in the PBLC+B cows
between 1 and 37 d after calving. Thus, our results are in partial contrast to a recent study
involving the same MON controlled-release capsule and the same PBLC (at 1 g/d without bio-
tin) in cows that were slightly more overconditioned (BCS = 3.95 ± 0.08) than the cows of the
present study. In the previous study, GGT and GLDH activities selectively increased in the
PBLC group during d 15 to d 56 after calving, indicating some degree of liver injury, whereas
MON cows appeared to be protected [59]. In the present study, by contrast, the reference
range of the analysing laboratory for AST (< 50 U/L), GGT (< 50 U/L) and GLDH (< 30 U/
L) was exceeded most frequently in the MON group, and group values of AST and GGT activi-
ties tended to be lower in PBLC+B cows in Phase 1. Therefore, future studies should determine
whether the increased GGT and GLDH activities observed by Drong et al. [59] after PBLC sup-
plementation were merely an incidental finding or whether the co-supplementation of biotin
should be routinely recommended to achieve optimum PBLC effects without compromising
the liver, at least in overconditioned cows.
The most striking finding of the present study was the effect of PBLC+B on BW. Because of
a negative energy balance, high-yielding dairy cows typically lose between 40 and 70 kg BW at
one to two months after calving [60–62]. A weight loss of ~70 kg was also observed in the
CON and MON groups in Phase 3 of the present study. The cows of the PBLC+B group, how-
ever, did not lose any significant weight and were the only group that had completely retained
their BW at the end of the study. The prevented weight loss after calving in the PBLC+B group
was partially reflected by a smaller loss of BFT; whereas, BCS points were not different for the
analyzed phases but only some individual time points. Therefore, the reason for the protection
against BW loss is not easily evident and probably includes any combination of lower mobili-
zation of body fat, lower mobilization of lean body mass and/or increased feed intake, i.e.
higher weight of the gastrointestinal tract. An argument in favour of an PBLC+B effect on feed
intake can be made from the expected stimulation of DM intake by biotin supplementation as
established by meta-analysis [39], whereas DM intake-increasing effects of PBLC have been
observed only occasionally [63]. The intakes of concentrates were not different among the
groups; however, as we were unable to record the intake of PMR in the present study, we can-
not proof or disproof stimulation of feed intake. Nonetheless, lower mobilization of body fat,
lower mobilization of lean body mass and increased feed intake can all be judged as positive
effects of PBLC+B on postpartum metabolic health and appear to distinguish PBLC+B from
MON. Monensin has a proven feed-depressing action [20, 56, 64], which partially counteracts
its several positive influences on postpartum metabolic health. The positive influence of MON
on postpartum BW has been quantified at 60 g/d in a meta-analysis [64], which appears consis-
tent with the results of the present study, but is far less than that observed for PBLC+B under
otherwise identical conditions.
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One frequently used criterion for judging the effects of a treatment on dairy cow metabo-
lism is milk performance. As expectable from meta-analysis [64], MON increased milk yield in
Phase 3 of the study; however, milk components responded primarily to PBLC+B treatment. A
trend for higher milk protein concentration was observed in the PBLC+B group on the first
herd test day. Interestingly, an almost identical trend for an increase in milk protein concen-
tration by 0.2% on the first (but not second) herd test day was observed in our preceding pilot
study involving PBLC+B on another farm [32]. The latter greatly substantiates the present
finding, despite the lack of statistical significance. Biotin is not known to affect milk protein
concentration [39]. Therefore, the increase in milk protein concentration may be attributed
either to the established effects of PBLC on milk protein output [31, 41] or to the combined
effect of both PBLC and biotin.
Milk fat concentration responded to treatment on the second test day when PBLC+B cows
showed higher values than MON cows, with CON cows being intermediate. A higher milk fat
percentage of the PBLC+B group was also indicated as a trend from the daily estimates of the
milking robot over the whole observation period (Phase 2 and Phase 3). Part of the contrast in
the milk fat concentration of PBLC+B vs. MON cows is probably attributable to the milk fat-
depressing action of MON. The latter has been linked to a higher concentration of trans-10
18:1 fatty acid in milk, indicative of the impaired bio-hydrogenation of linoleic acid in the
rumen [54, 65]. Trans-10 18:1 fatty acid, on the other hand, is a potent inhibitor of milk fat
synthesis [66]. Alternatively, a higher milk fat concentration could also, in part, result from
enhanced milk fat synthesis during PBLC+B treatment. An increase in milk fat concentration
is not typically observed when PBLC supplementation of cows is applied after the transition
period [31, 65]. However, an increase in milk fat percentage has been seen in high-conditioned
(BCS 3.95) transition cows with restricted concentrate feeding and PBLC supplementation, as
reported by Drong et al. [21]. The latter authors suggested that this might be attributable to the
enhanced clearance of circulating NEFA by the mammary gland in PBLC-supplemented cows.
Biotin supplementation could theoretically also stimulate milk fat synthesis, although this is
not typically seen in dairy cows [39]. However, a key role of biotin for fatty acid synthesis in
the bovine mammary gland is deductible from the profound inhibition of mammary fatty acid
synthesis by the biotin antagonist avidin [67], supporting the view that an increased supply of
biotin as cofactor of acetyl-CoA synthase can enhance lipid generation from ruminally-pro-
duced acetate.
The differences in the milk fat concentration together with a milk yield intermediate
between CON and MON resulted in increased yields of energy-corrected milk for PBLC+B vs.
CON cows of ~3 to 4 kg/d in both treatment phases. Moreover, ECM yield was also higher in
PBLC+B cows compared to MON cows in Phase 2. This conforms with results of previous
studies with the used PBLC at dosages of 1 to 2 g/d per cow [32, 41, 63] and with results of a
meta-analysis of 238 cows in 11 trials with biotin at dosages of 20 mg/d per cow, showing an
increase in daily milk yield. Notably, this increase in ECM yield was associated with lower BW
loss and was, as such, not produced at the expense of body condition.
Conclusion
Negative energy balance and excessive BW loss are major challenges that coincide with sub-
clinical ketosis and associated diseases in postpartum dairy cows. The key result of the present
study is that a combination of PBLC+B prevents body weight loss after parturition almost
completely. Future studies will have to elucidate to what extent this PBLC+B effect is attribut-
able to a better conservation of body fat, a better conservation of lean body mass and/or an
increased DM intake. Supplementation of PBLC+B were further associated with a similar
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ketosis incidence and partly higher yields of energy-corrected milk compared with MON-sup-
plemented cows. Thus, the PBLC+B treatment appears to be an attractive alternative to MON
supplementation in transition dairy cows, with a high potential of reducing antibiotic use in
agriculture.
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